Qing Sheng
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 6
- Ubiquitin and proteasome pathways 5
- Heat shock proteins research 4
- Circular RNAs in diseases 4
- Oncology 18
- HER2/EGFR in Cancer Research 8
- Co-authors
- David M. Livingston (3 shared papers)Bing Xia (2 shared papers)Xinggang Liu (2 shared papers)Jun S. Liu (1 shared paper)Maria Jasin (1 shared paper)Jianmin Wu (1 shared paper)Nicole Christ (1 shared paper)Fergus J. Couch (1 shared paper)
- Journals
- Cancer Research (7 papers)Applied Biochemistry and Biotechnology (4 papers)Archives of Insect Biochemistry and Physiology (3 papers)PLoS ONE (3 papers)BMC Genomics (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Qing Sheng
75 papers receiving 2.7k citations
Qing Sheng's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 523
- Oncology 766
- Molecular Biology 1.6k
- Genetics 537
- Reproductive Medicine 94
Countries citing papers authored by Qing Sheng
This map shows the geographic impact of Qing Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Sheng more than expected).
Fields of papers citing papers by Qing Sheng
This network shows the impact of papers produced by Qing Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Sheng. The network helps show where Qing Sheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Qing Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2 Hit paper breakdown → | 2006 | 646 |
| 2 | 2006 | 351 | |
| 3 | 2010 | 179 | |
| 4 | 2011 | 144 | |
| 5 | 2014 | 142 | |
| 6 | 2014 | 78 | |
| 7 | 1997 | 76 | |
| 8 | 2013 | 72 | |
| 9 | 2011 | 66 | |
| 10 | 2008 | 62 | |
| 11 | 2010 | 56 | |
| 12 | 2007 | 54 | |
| 13 | 2013 | 46 | |
| 14 | 2013 | 46 | |
| 15 | 2019 | 45 | |
| 16 | 2020 | 42 | |
| 17 | 2010 | 36 | |
| 18 | 2013 | 35 | |
| 19 | 2015 | 30 | |
| 20 | 2015 | 29 |
About Qing Sheng
Qing Sheng is a scholar working on Molecular Biology, Oncology, Plant Science, Pulmonary and Respiratory Medicine and Cancer Research, having authored 77 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Histone Deacetylase Inhibitors Research (6 papers), MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Silk-based biomaterials and applications (5 papers), Heat shock proteins research (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (523 citations), Oncology (766 citations), Molecular Biology (1.6k citations), Genetics (537 citations) and Reproductive Medicine (94 citations). Qing Sheng has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include David M. Livingston, Bing Xia, Xinggang Liu, Jun S. Liu, Maria Jasin, Jianmin Wu, Nicole Christ, Fergus J. Couch, Akihiro Ohashi and Koji Nakanishi. Their work appears in journals such as Cancer Research, Applied Biochemistry and Biotechnology, Archives of Insect Biochemistry and Physiology, PLoS ONE and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.